Thermo Fisher Scientific invests $2B to expand life sciences manufacturing facilities in the United States
Thermo Fisher Scientific has announced plans to expand its life sciences manufacturing facilities across the United States. The company, which enables biopharma companies to develop and produce medicines, is investing $2 billion into the expansion and supporting the creation of high-paying jobs nationwide.
The investment includes $1.5 billion in capital expenditures to enhance and expand U.S. manufacturing operations, along with $500 million dedicated to research and development. Thermo Fisher operates 64 manufacturing sites in 37 states, producing analytical instruments, specialty diagnostics, and life sciences solutions. The company also provides contract development and manufacturing services to pharmaceutical innovators.
What people are saying
In a recent quote, Marc N. Casper, chairman, president and chief executive officer, Thermo Fisher Scientific, said, “Thermo Fisher’s commitment to U.S. manufacturing reflects our confidence that America will continue to lead the world in science and innovation. Thermo Fisher is proud to serve as a growth engine for the American economy. By expanding our U.S. operations, we ensure that life-saving medicines and therapies will continue to be developed and produced in America for decades to come.”
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.